These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18719506)

  • 21. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease?
    Kadokawa Y; Omagari K; Ohba K; Masuda J; Hazama H; Kinoshita H; Ohnita K; Mizuta Y; Tanioka H; Imanishi T; Kohno S
    Liver Int; 2005 Apr; 25(2):317-24. PubMed ID: 15780056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Am J Gastroenterol; 2007 May; 102(5):1005-12. PubMed ID: 17319926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis.
    Rigopoulou EI; Davies ET; Bogdanos DP; Liaskos C; Mytilinaiou M; Koukoulis GK; Dalekos GN; Vergani D
    Liver Int; 2007 Nov; 27(9):1226-31. PubMed ID: 17919234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimitochondrial antibody-negative primary biliary cirrhosis.
    Mendes F; Lindor KD
    Gastroenterol Clin North Am; 2008 Jun; 37(2):479-84, viii. PubMed ID: 18499032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune liver disease 2007.
    Muratori P; Granito A; Pappas G; Muratori L; Lenzi M; Bianchi FB
    Mol Aspects Med; 2008; 29(1-2):96-102. PubMed ID: 18067956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4.
    Czaja AJ; Carpenter HA; Moore SB
    Liver Int; 2006 Jun; 26(5):552-8. PubMed ID: 16761999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Hepatology; 2007 Oct; 46(4):1138-45. PubMed ID: 17668882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis.
    Czaja AJ; Menon KV; Carpenter HA
    Hepatology; 2002 Apr; 35(4):890-7. PubMed ID: 11915036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and serological follow-up of 71 patients with anti-mitochondrial type 5 antibodies.
    Andrejevic S; Bonaci-Nikolic B; Sefik-Bukilica M; Petrovic R
    Lupus; 2007; 16(10):788-93. PubMed ID: 17895301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune hepatitis. Part B: diagnosis.
    Czaja AJ
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):129-43. PubMed ID: 19072441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimonocyte antibodies in Takayasu's arteritis: prevalence of and relation to disease activity.
    Tripathy NK; Sinha N; Nityanand S
    J Rheumatol; 2003 Sep; 30(9):2023-6. PubMed ID: 12966610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.
    Hausdorf G; Roggenbuck D; Feist E; Büttner T; Jungblut PR; Conrad K; Berg C; Klein R
    Clin Chim Acta; 2009 Oct; 408(1-2):19-24. PubMed ID: 19576873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis.
    Czaja AJ; Carpenter HA
    Hepatology; 2004 Jun; 39(6):1631-8. PubMed ID: 15185304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.
    Eyraud V; Chazouilleres O; Ballot E; Corpechot C; Poupon R; Johanet C
    Liver Int; 2009 Jul; 29(6):857-64. PubMed ID: 19302185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.
    Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R
    Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autoimmune manifestations in acute viral hepatitides].
    Volchkova EV; Allenov MN; Umbetova KT; Ivanova IV; Pak SG
    Ter Arkh; 2003; 75(11):11-4. PubMed ID: 14708433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune hepatitis in children: what is different from adult AIH?
    Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapidity of treatment response and outcome in type 1 autoimmune hepatitis.
    Czaja AJ
    J Hepatol; 2009 Jul; 51(1):161-7. PubMed ID: 19446908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
    Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
    Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome.
    Hatzis GS; Fragoulis GE; Karatzaferis A; Delladetsima I; Barbatis C; Moutsopoulos HM
    J Rheumatol; 2008 Oct; 35(10):2012-6. PubMed ID: 18709690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.